Delivery Order SPE2DB22D1200-SPE2DB25FN3RT
Award Date 8/7/25
Potential Completion Date 8/8/25
Potential Value $2.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Azstarys 39.2 mg-7.8 mg capsules (100-count packaging) with a ceiling value of $1,436.84. This competitively awarded, non-set-aside delivery order represents a firm fixed-price contract with an ultimate completion date of August 8, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a...
- The Defense Logistics Agency awarded a $5,531.10 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Azstarys 26.1 mg–5.2 mg capsules (100 count). This is a non-set-aside competitive award with an ultimate completion date of August 15, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support...
- This delivery order, valued at $1,436.84, awards AmerisourceBergen Drug Corp a competitively awarded, firm fixed-price contract for the supply of Azstarys 39.2 mg-7.8 mg capsules (100-count units) effective through September 16, 2025. The award was made by the Medical Supply Chain, a defense-focused federal agency responsible for pharmaceutical procurement to support military and veteran healthcare systems. The contract carries no set-aside designation, indicating open competition among eligible...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,668.99 on August 18, 2025, for the supply of Azstarys 52.3 mg-10.4 mg capsules (100-count unit). This firm fixed-price contract was competitively awarded with no set-aside designation and carries an ultimate completion date of August 19, 2025. The contract is funded through the Defense Logistics Agency's Medical Supply Chain, reflecting the...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for $2,046.80 on June 16, 2025, with an ultimate completion date of June 17, 2025. This competitively awarded, firm fixed-price delivery order covers the supply of AZSTARYS Capsules (39.2mg/7.8mg), a prescription medication used for attention deficit hyperactivity disorder treatment. No set-aside designation was applied to this contract. The vendor, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,313.06 to AmerisourceBergen Drug Corp for AZSTARYS 26.1 mg-5.2 mg capsules (100-count supply). This firm fixed price, non-set-aside delivery order was awarded on June 30, 2025, with an ultimate completion date of July 1, 2025. The contract represents a standard pharmaceutical procurement under the Defense Logistics Agency's medical supply operations, with performance taking place at AmerisourceBergen's corporate office location...
- AmerisourceBergen Drug Corp has been awarded a delivery order for AZSTARYS Capsules (39.2mg/7.8mg) valued at $1,567.95 by the Defense Department's Medical Supply Chain division. This competitively awarded, non-set-aside contract is priced on a firm fixed-price basis with a completion date of June 3, 2025. The pharmaceutical product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate operations as a major healthcare...
- The Defense Logistics Agency Medical Supply Chain awarded a $4,848.20 delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for AZSTARYS capsules (39.2mg/7.8mg), a prescription medication used in the treatment of attention-deficit/hyperactivity disorder. This firm fixed price, non-set-aside contract is scheduled for completion by September 12, 2025, with performance occurring at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for AZSTARYS Capsules 39.2mg/7.8mg, a pharmaceutical product used in the treatment of attention-deficit/hyperactivity disorder. This firm fixed-price delivery order, valued at $5,307.13, is scheduled for completion by August 29, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was awarded without a...
- The Defense Logistics Agency awarded a $4,797.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp for AZSTARYS (aripiprazole) 26.1 mg-5.2 mg capsules, quantity 100 units, with a completion date of September 9, 2025. This non-set-aside competitive award represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply contract vehicle with DLA. The Place of Performance is listed as Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate...